Business Description
Ypsomed Holding AG
ISIN : CH0019396990
Share Class Description:
LTS:0QLQ: Ordinary SharesTotal Employee Number:
2,099Description
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | 0.8 | |||||
Interest Coverage | 77.36 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 6.79 | |||||
Beneish M-Score | -2.86 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.2 | |||||
3-Year EBITDA Growth Rate | 32.8 | |||||
3-Year EPS without NRI Growth Rate | 62.2 | |||||
3-Year FCF Growth Rate | 25.9 | |||||
3-Year Book Growth Rate | 11.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.56 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.83 | |||||
9-Day RSI | 65.25 | |||||
14-Day RSI | 65.1 | |||||
3-1 Month Momentum % | 20.48 | |||||
6-1 Month Momentum % | 2.9 | |||||
12-1 Month Momentum % | -19.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.07 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 63.05 | |||||
Days Sales Outstanding | 83.7 | |||||
Days Payable | 29.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.61 | |||||
Dividend Payout Ratio | 0.22 | |||||
3-Year Dividend Growth Rate | 54.2 | |||||
Forward Dividend Yield % | 1.21 | |||||
5-Year Yield-on-Cost % | 5.08 | |||||
3-Year Average Share Buyback Ratio | 1.2 | |||||
Shareholder Yield % | 6.02 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 43.04 | |||||
Operating Margin % | 33.66 | |||||
Net Margin % | 30.36 | |||||
EBITDA Margin % | 44.65 | |||||
FCF Margin % | -2.24 | |||||
OCF Margin % | 41.97 | |||||
ROE % | 29.79 | |||||
ROA % | 17.13 | |||||
ROIC % | 18.38 | |||||
3-Year ROIIC % | 47.06 | |||||
ROC (Joel Greenblatt) % | 31.48 | |||||
ROCE % | 25.82 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 22.57 | |||||
Forward PE Ratio | 22.05 | |||||
PE Ratio without NRI | 36.77 | |||||
Shiller PE Ratio | 73.52 | |||||
Price-to-Owner-Earnings | 26.16 | |||||
PEG Ratio | 1.14 | |||||
PS Ratio | 6.85 | |||||
PB Ratio | 6.46 | |||||
Price-to-Tangible-Book | 7.77 | |||||
Price-to-Operating-Cash-Flow | 16.32 | |||||
EV-to-EBIT | 20.37 | |||||
EV-to-Forward-EBIT | 31.22 | |||||
EV-to-EBITDA | 15.23 | |||||
EV-to-Forward-EBITDA | 17.45 | |||||
EV-to-Revenue | 6.81 | |||||
EV-to-Forward-Revenue | 6.45 | |||||
EV-to-FCF | -303.79 | |||||
Price-to-GF-Value | 0.91 | |||||
Price-to-Median-PS-Value | 1.34 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.9 | |||||
Price-to-Graham-Number | 3.56 | |||||
Earnings Yield (Greenblatt) % | 4.9 | |||||
FCF Yield % | -0.35 | |||||
Forward Rate of Return (Yacktman) % | 18.96 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ypsomed Holding AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 730.982 | ||
| EPS (TTM) (CHF) | 16.3 | ||
| Beta | 0.053 | ||
| 3-Year Sharpe Ratio | 0.41 | ||
| 3-Year Sortino Ratio | 0.76 | ||
| Volatility % | 40.5 | ||
| 14-Day RSI | 65.1 | ||
| 14-Day ATR (CHF) | 7.648863 | ||
| 20-Day SMA (CHF) | 353.30147 | ||
| 12-1 Month Momentum % | -19.81 | ||
| 52-Week Range (CHF) | 263.5 - 440 | ||
| Shares Outstanding (Mil) | 13.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ypsomed Holding AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ypsomed Holding AG Stock Events
| Event | Date | Price (CHF) | ||
|---|---|---|---|---|
| CHF 4.400000 Cash Dividend | 2026-07-03 | 363.00 (-0.60%) | ||
| CHF 2.200000 Cash Dividend | 2025-07-04 | 417.50 (-0.24%) |
Show
Entries
Ypsomed Holding AG Frequently Asked Questions
What is Ypsomed Holding AG(LTS:0QLQ)'s stock price today?
The current price of LTS:0QLQ is CHF362.80. The 52 week high of LTS:0QLQ is CHF440.00 and 52 week low is CHF263.50.
When is next earnings date of Ypsomed Holding AG(LTS:0QLQ)?
The next earnings date of Ypsomed Holding AG(LTS:0QLQ) is .
Does Ypsomed Holding AG(LTS:0QLQ) pay dividends? If so, how much?
The Dividend Yield %  of Ypsomed Holding AG(LTS:0QLQ) is 0.61% (As of Today), Highest Dividend Payout Ratio of Ypsomed Holding AG(LTS:0QLQ) was 0.86. The lowest was 0.14. And the median was 0.31. The  Forward Dividend Yield % of Ypsomed Holding AG(LTS:0QLQ) is 1.21%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Ypsomed Holding AG
No articles.